• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE CR FEM RT SZ 3 CEM; ATTUNE IMPLANT : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE CR FEM RT SZ 3 CEM; ATTUNE IMPLANT : KNEE FEMORAL Back to Search Results
Model Number 1504-00-203
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Adhesion(s) (1695); Pain (1994); Joint Laxity (4526)
Date of Event 11/10/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint #: (b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Patient received a right primary attune to treat severe osteoarthritis.The patella was resurfaced and depuy cement x1 was utilized.The procedure was completed without complications.Patient¿s right knee was revised to treat pain and instability secondary to suspected tibial tray loosening.Upon entering the joint, the surgeon identified and excised periarticular scar tissue.The tibial tray was loosened and debonded at the cement to implant interface and revised.The femoral component was well-fixed but revised to accommodate the revision products.There was no reported product problem with the revised tibial insert.The patella was retained.The patient was revised with a competitor revision knee construct.The procedure was completed without complications.Doi: (b)(6) 2014, dor: (b)(6) 2020, right knee.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE CR FEM RT SZ 3 CEM
Common Device Name
ATTUNE IMPLANT : KNEE FEMORAL
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key12363707
Report Number1818910-2021-18564
Device Sequence Number4333164
Product Code JWH
UDI-Device Identifier10603295041184
UDI-Public10603295041184
Combination Product (Y/N)N
Initial Reporter StateCT
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2014
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 08/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/05/2023
Device Model Number1504-00-203
Device Catalogue Number150400203
Device Lot Number365558
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 08/06/2021
Supplement Date Received by Manufacturer08/27/2021
Initial Report FDA Received Date08/24/2021
Supplement Report FDA Received Date08/30/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE CR FB INSRT SZ 3 5MM; ATTUNE CR FEM RT SZ 3 CEM; ATTUNE FB TIB BASE SZ 4 CEM; ATTUNE MEDIAL DOME PAT 32MM; SMARTSET MV 40G - EO; ATTUNE CR FB INSRT SZ 3 5MM; ATTUNE CR FEM RT SZ 3 CEM; ATTUNE FB TIB BASE SZ 4 CEM; ATTUNE MEDIAL DOME PAT 32MM; SMARTSET MV 40G - EO
Outcome Attributed to Adverse Event Required Intervention;
Patient Age54 YR
-
-